Resultados de eficácia histadin d

HISTADIN D com posologia, indicações, efeitos colaterais, interações e outras informações. Todas as informações contidas na bula de HISTADIN D têm a intenção de informar e educar, não pretendendo, de forma alguma, substituir as orientações de um profissional médico ou servir como recomendação para qualquer tipo de tratamento. Decisões relacionadas a tratamento de pacientes com HISTADIN D devem ser tomadas por profissionais autorizados, considerando as características de cada paciente.



O uso de loratadina + sulfato de pseudoefedrina xarope está embasado em estudos realizados com outras formas farmacêuticas1,2,3,4,5 desta associação, em estudos patrocinados6,7,8,9 e em literaturas publicadas10,11,12,13.

Referências bibliográficas:
1.A Double-Blind, Placebo-Controlled Study of the Effect of SCH 434 Compared to its Components in Patients with Seasonal Allergic Rhinitis. S85-034. Schering-Plough Corporation, Kenilworth, NJ.

2.A Double-Blind, Placebo-Controlled Study of the Effect of SCH 434 Compared to its Components in Patients with Seasonal Allergic Rhinitis, I86-305. Schering-Plough Corporation, Kenilworth, NJ.

3.A Double-Blind, Placebo-Controlled Study of the Effect of SCH 434 Compared to its Components in Patients with Seasonal allergic Rhinitis. S85-033. Schering-Plough Corporation, Kenilworth, NJ.

4.A Double-Blind, Placebo-Controlled Study of the Effect of SCH 434 Compared to its Components in Patients with Seasonal Allergic Rhinitis. I86-203/304. Schering-Plough Corporation, Kenilworth, NJ.

5.A Study of the Safety and Efficacy of SCH 434 Compared with Placebo in Patients with Seasonal Allergic Rhinitis. S85- 035.Schering-Plough Corporation, Kenilworth, NJ.

6.Prieto U et al. Efficacy and safety of three different dosages of loratadine associated with pseudoephedrine, in children with allergic rhinitis. SCH 434 P92-002 Mexico Children’s Hospital, Mexico City, Mexico April 1993.

7.Davila Velazquez et al. Therapeutic Evaluation of Antihistamine and Pseudoephedrine Combinations in Children with Perennial Allergic Rhinitis. Invest Med Int 1993;(20):85-91.

8.González Gámez J et al. Efficacy and Safety of Two New Generation Antihistamines Associated to Pseudoephedrine in the Treatment of Children with Allergic Rhinitis: A Comparative Study. Invest Med Int 1993;(20):80-84.

9.Sánchez García M et al. Efficacy and Safety of Loratadine Plus Pseudoephedrine, Pediatric Solution, in Children with Allergic Rhinitis. Invest Med Int 1993;(20):92-98.

10.Cruz et al. A comparative study between astemizole-D and loratadine-D in the treatment of seasonal allergic rhinitis. Invest Med Int (Mexico) 1993;20(4):147-154.

11.Trejo Tapia D et al. Hacia un major control sintomatico de rinitis alergica. Invest Med Int (Mexico) 1993;20(2):76-79.

12.Paz Martinez D et al. Comparative assessment of astemizole-pseudoephedrine and loratadine pseudoephedrine in children with allergic rhinitis. Rev Alerg Mex. 1995;42(6):105-109.

13.Serra HA. Loratadine pseudoephedrine in children with allergic rhinitis: A controlled double-blind trial. Br J Clin Pharmacol1998;45(2):147-150.